Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Trial to Evaluate Target Occupancy of Scopolamine at the Muscarinic M1 Receptor

NCT06014385 is registered in ClinicalTrials.gov with Yale University as lead sponsor.

NCT NCT06014385
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06014385 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Trial to Evaluate Target Occupancy of Scopolamine at the Muscarinic M1 Receptor
Lead sponsor
Yale University
Phase
Phase 1
Overall status
Withdrawn
Start date
March 31, 2025
Completion date
July 1, 2025
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

muscarinic receptor occupancy